New perspectives drive paradigms in dry eye diagnosis, treatment

Article

Recent research has created new perspectives on tear film dysfunction and ocular surface disease that is driving the development of new therapeutic concepts along with innovations in diagnosis and treatment.

Key Points

Orlando, FL-Recent research has created new perspectives on tear film dysfunction and ocular surface disease that is driving the development of new therapeutic concepts along with innovations in diagnosis and treatment, said Arthur B. Epstein, OD, at the annual meeting of the American Academy of Optometry.

He explained that the ocular surface and tear film can be thought of as a unique external environment created by the body. However, it is a complex microenvironment that consists of multiple components and that is continuously exposed to potentially disrupting factors within a macroenvironment.

Defects in the lipid, aqueous, and mucin components of the tear film can precipitate dry eye disease.

"Breakdown in the lipid, aqueous, or mucin components of the tear film can lead to dry eye, and the precipitating factor doesn't matter. Regardless of what that is, a perpetuating cyclic process is induced that leads to inflammation. Inflammation as a feature of dry eye disease develops as a last-ditch compensatory effort to fix a disrupted environment," he said.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Brett Bielory, MD, at ASCRS 2025
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
© 2025 MJH Life Sciences

All rights reserved.